| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/08/1991 | EP0426066A2 Ace inhibitors for use for preventing onset of type II diabetes |
| 05/08/1991 | EP0425956A2 ACE inhibitors for use for stabilizing or causing regression of atherosclerosis in coronary arteries |
| 05/08/1991 | EP0425909A2 Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor |
| 05/08/1991 | EP0425507A1 Compositions and methods for treating skin conditions and promoting wound healing. |
| 05/07/1991 | US5013756 Catechol derivatives, a process of preparation thereof, and therapeutical compositions containing the same |
| 05/07/1991 | US5013719 Administering cyclosporin A and alpha-difluoromethylornithine |
| 05/02/1991 | DE3936328A1 Pharmazeutische praeparate Pharmaceutical products |
| 05/01/1991 | CA2026686A1 Method for preventing onset of type ii diabetes employing an ace inhibitor |
| 04/30/1991 | US5011684 Administering monoclonal antibody to interleukin receptor |
| 04/30/1991 | CA1283604C2 Dehydrated liposomes |
| 04/24/1991 | EP0424179A2 Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration |
| 04/24/1991 | EP0423943A2 Use of collagenase inhibitors in the treatment of demyelinating diseases, in particular multiple sclerosis |
| 04/24/1991 | EP0423695A2 Aerosol composition for topical medicament |
| 04/24/1991 | CA2026642A1 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor |
| 04/24/1991 | CA2026602A1 Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor |
| 04/23/1991 | US5010056 Pharmaceutical composition for intranasal administration, comprising GH-releasing hormone, a cholinergic agonist and optionally a bile salt |
| 04/23/1991 | CA1283361C Antiviral combinations |
| 04/23/1991 | CA1283357C Thrombosis treatment with fibrinolytics and prostacyclins |
| 04/20/1991 | WO1991006005A1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
| 04/20/1991 | CA2027952A1 Topical medicinal pressurized aerosol compositions and method of preparation, method of use and article of manufacture thereof |
| 04/18/1991 | WO1991005038A1 Blood-brain barrier model |
| 04/18/1991 | WO1991004757A1 Effervescent dosage form and method of administering same |
| 04/18/1991 | WO1991004664A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 04/18/1991 | CA2066046A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 04/17/1991 | EP0422681A1 Collagen containing ophthalmic formulation |
| 04/17/1991 | EP0422097A1 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo. |
| 04/16/1991 | CA1283052C Medicament depot |
| 04/14/1991 | CA2027433A1 Collagen containing ophthalmic formulation |
| 04/10/1991 | EP0421733A2 Amphotericin B lipid complex |
| 04/10/1991 | EP0421508A2 Sulphated glycosaminoglycuronan with antithrombotic activity |
| 04/09/1991 | US5006560 Use of GABA-B selective agonists as anti-tussive agents |
| 04/09/1991 | CA1282699C Method for preparing small vesicles using microemulsification |
| 04/04/1991 | WO1991004055A1 Treatment of autoimmune disease |
| 04/04/1991 | WO1991004039A1 Erection-inducing methods and compositions |
| 04/04/1991 | WO1991004037A1 Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
| 04/04/1991 | WO1991004032A1 Methods of treating neurodegenerative conditions |
| 04/04/1991 | WO1991004030A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
| 04/04/1991 | WO1991004024A1 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 04/04/1991 | CA2066716A1 Use of steroid hormones in compositions for inducing t cell lymphokine production |
| 04/04/1991 | CA2012101A1 Antiviral medicinal composition |
| 04/03/1991 | WO1991004751A1 Inhibitor of absorption of digestion product of food and drink |
| 04/03/1991 | EP0419856A2 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates |
| 04/03/1991 | EP0419501A1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components. |
| 04/03/1991 | EP0242380B1 A process for preparing immunogenic complex |
| 04/03/1991 | CA2067353A1 Inhibitor of absorption of digestion product of food and drink |
| 04/03/1991 | CA2024781A1 Method for treating systemic candida infections with a single dose administration of amphotericin b lipid complex |
| 04/02/1991 | US5004601 Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
| 03/29/1991 | CA2023857A1 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates |
| 03/27/1991 | EP0419387A1 Hydrophilic derivatives, diagnostic and therapeutic applications, kits and immunological reagents |
| 03/27/1991 | EP0418674A1 Pharmaceutical preparations for enhanced absorption of antibacterial compounds |
| 03/27/1991 | EP0418597A2 Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
| 03/27/1991 | EP0418582A2 Method for treating hypermotility diseases of the bowel employing an ace inhibitor |
| 03/27/1991 | EP0418564A1 Effervescent cold or sinus allergy medicine composition having reduced sodium content |
| 03/27/1991 | EP0418316A1 Platelet-specific chimeric immunoglobulin |
| 03/26/1991 | WO1991004479A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress |
| 03/26/1991 | CA2067123A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress |
| 03/26/1991 | CA1282005C Antiglaucoma compositions and process for their preparation |
| 03/22/1991 | WO1991004058A2 Treatment of conditions and disease |
| 03/22/1991 | CA2042034A1 Treatment of conditions and disease |
| 03/22/1991 | CA2025763A1 Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
| 03/21/1991 | WO1991003234A1 Drug containing matrix |
| 03/20/1991 | EP0417927A1 Detection and treatment of infections with immunoconjugates |
| 03/20/1991 | EP0417637A2 Use of dopamine autoreceptor agonists in the treatment of drug dependency |
| 03/20/1991 | EP0417209A1 Compositions and methods for administering therapeutically active compounds |
| 03/20/1991 | EP0417188A1 Protein crosslinking reagents cleavable within acidified intracellular vesicles |
| 03/20/1991 | EP0341264A4 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
| 03/19/1991 | WO1991004031A1 Oral anticoagulant/platelet inhibitor low dose formulation |
| 03/19/1991 | US5001115 Prodrugs of biologically active hydroxyaromatic compounds |
| 03/19/1991 | CA2065347A1 Oral anticoagulant/platelet inhibitor low dose formulation |
| 03/13/1991 | EP0416722A2 Pharmaceutical compositions having differential drug release rate |
| 03/13/1991 | EP0416604A2 PAF-antagonists for the preparation of a medicament, useful for the treatment of heart diseases, caused by diminished beta-receptor-stimulation |
| 03/13/1991 | EP0416011A1 Chemotherapeutic composition for aids |
| 03/13/1991 | EP0185762B1 Cell-delivery agent |
| 03/12/1991 | US4999435 Cationic Surfactants, Drugs, Immunoassay |
| 03/12/1991 | US4999382 Compositions for treating tobacco withdrawal symptoms and methods for their use |
| 03/12/1991 | US4999370 Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system |
| 03/12/1991 | US4999188 Methods for embolization of blood vessels |
| 03/12/1991 | CA2025003A1 Use of dopamine-autoreceptor agonists in the treatment of drug dependency |
| 03/12/1991 | CA2024887A1 Pharmaceutical preparations |
| 03/12/1991 | CA1281286C Oxytocin and antigestagen for induction of birth |
| 03/09/1991 | WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas |
| 03/08/1991 | CA2024630A1 Paf-antagonists for the preparation of a pharmaceutical composition suitable for treating heart diseases caused by reduced stimulation of .beta.-receptors |
| 03/07/1991 | WO1991003099A1 Compressed powder medicaments |
| 03/07/1991 | WO1991002541A1 Detection and treatment of infections with immunoconjugates |
| 03/07/1991 | WO1991002540A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 03/07/1991 | WO1991002527A1 Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists |
| 03/07/1991 | WO1991002518A1 Pharmaceutical compositions and a device for administering the same |
| 03/07/1991 | CA2065375A1 Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists |
| 03/07/1991 | CA2064882A1 Pharmaceutical compositions and a device for administering the same |
| 03/06/1991 | EP0415693A1 Composition and method for selective enhancement of opiate activity and reduction of opiate tolerance and dependence |
| 03/06/1991 | EP0415623A2 Toremifene or demethyltoremifene as hydroxytoremifene for the reversal of multidrug restistance of cancer cells against cytotoxic drugs |
| 03/06/1991 | EP0415567A2 Composition and method for stabilising organic compounds |
| 03/06/1991 | EP0414730A1 Luminide and macroluminide class of pharmaceuticals |
| 03/05/1991 | US4997913 pH-sensitive immunoconjugates and methods for their use in tumor therapy |
| 03/05/1991 | US4997851 Antiviral and antibacterial activity of fatty acids and monoglycerides |
| 03/05/1991 | US4997658 Method for enhancing the lowering of plasma cholesterol levels |
| 03/02/1991 | CA2021548A1 Effervescent cold or sinus allergy medicine composition having reduced sodium content |
| 03/01/1991 | CA2021408A1 Method for treating hypermotility diseases of the bowel employing an ace inhibitor and formulation for use therein |
| 02/27/1991 | EP0414605A1 Pasty aqueous pharmaceutical compositions |
| 02/27/1991 | EP0413929A2 Use of an ace-inhibitor to treat or prevent depression |